Gradientech
Business Services · Sweden · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Science Park 751 83, Uppsala, Uppsala, S...Phone Number
+46 184186700Website
www.gradientech.seRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Gradientech
Gradientech specializes in ultra-rapid antibiotic susceptibility testing (AST) with its innovative QuickMIC® system, which delivers reliable minimum inhibitory concentration (MIC) results in just 2-4 hours. The technology is designed to enhance laboratory efficiency and support clinicians in making informed treatment decisions for sepsis patients. By providing precise and timely results, Gradientech aims to combat antibiotic resistance and improve patient outcomes. Their target clients include clinical laboratories and healthcare providers focused on rapid diagnostics and effective sepsis management.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Gradientech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Gradientech, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Gradientech has new funding data
Check out if Gradientech is spiking on competitors!
Product Launch: Get notified when Gradientech launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Gradientech has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if Gradientech had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Gradientech
Earning: See what the market has to say on Gradientech recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Gradientech is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Gradientech is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Gradientech.
Gradientech Tech Stack
A closer look at the technologies used by Gradientech
See more technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Lateral Move
Executive Move
Lateral Move
Executive Move
Gradientech News & Media
First QuickMIC[®] agreement signed for clinical routine use in Italy
The diagnostics company Gradientech announces the successful implementation of the QuickMIC[®] system for ultra-rapid antibiotic susceptibility testing (AST) into clinical routine use at the Molinette Hospital in Turin, Italy. The Molinette Hospital is as part of the Azienda Ospedaliero Universitaria (AOU) Città della Salute e della Scienza di Torino, one of the biggest university hospitals in Italy and in Europe, with a mission to provide excellent patient care and conduct top-tier research. "AGradientech presented QuickMIC® performance data at the 17th National Microbiology Conference in Romania
The diagnostics company Gradientech announces the presentation of newly published outstanding performance data on QuickMIC® at the 17th National Conference of Microbiology and Epidemiology in Iași, Romania, 7-9 November 2024. The national conference in Iași brought together experts in infectious diseases and clinical microbiology from across Romania to discuss urgent public health challenges. The sessions addressed various topics, including innovative diagnostics and infection prevention strategGradientech: Interim report January–September 2024
Gradientech AB (publ) interim report for Q3 2024 is now available on the company's website www.gradientech.se. Third quarter 2024 · Net sales amounted to SEK 829 thousand (53). · Net profit/loss amounted to SEK -13,399 thousand (-10,968). · Earnings per share before and after dilution were SEK -0.51 (-0.62). · Cash flow from operating activities amounted to SEK -13,906 thousand (-14,435). · Cash and cash equivalents amounted to SEK 13,142 thousand (25,873) as of SeptemberHardy Diagnostics announces exclusive partnership for the US and Canada with Gradientech for the commercialization of the QuickMIC® system
QuickMIC® is an ultra-rapid antimicrobial susceptibility testing (AST) system designed to provide critical results for sepsis patients SANTA MARIA, Calif., Oct. 28, 2024 /PRNewswire/ -- This month Hardy Diagnostics entered into an exclusive partnership with the Swedish-based company...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Gradientech
Sign Up For FreeTo access detailed company insights
Gradientech specializes in ultra-rapid antibiotic susceptibility testing (AST) with its innovative QuickMIC® system, which delivers reliable minimum inhibitory concentration (MIC) results in just 2-4 hours. The technology is designed to enhance laboratory efficiency and support clinicians in making informed treatment decisions for sepsis patients.... Read More
